Pfizer posts earnings of 58 cents a share vs. 57 cents estimate

Analysts had expected the company to report earnings of 57 cents a share on $12.46 billion in revenue, according to a consensus estimate from Thomson Reuters. Analysts expect Pfizer to approach AstraZeneca again in the coming months, even though the British pharma firm rejected Pfizer's " final" takeover bid back in May.